Company Profile
Forty51 Ventures is a biotech venture creator and early-stage investor in European biotech companies, focusing on opportunities with a clear path to the clinic. They invest in therapeutic areas such as CNS, oncology, immunology and inflammation, fibrotic disorders, and ophthalmology.
News & Signals (0)
No linked news activity found for this company.
Investor Listings
No investor listings assigned to this company yet.